# Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients

> **NCT00734630** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 491 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** nebivolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00734630
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-05
- **Target enrollment:** 491 (ACTUAL)
- **Last updated:** 2011-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00734630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00734630, "Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00734630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*